Bazedoxifene vs. RaloxifeneActivity on Bone Markers

Percent

Decrease

in Bone

Markers

Data from Wyeth’s Analyst Meeting 5/16/01

Raloxifene

60 mg.

Bazedoxifene

20 mg.

Bazedoxifene

40 mg.

P = .001 for All Treatments Relative to Placebo

Results of Phase II Study

Previous slide

Next slide

Back to first slide

View graphic version